Literature DB >> 27607853

Pharmacologic Thromboprophylaxis in Obstetrics: Broader Use Demands Better Data.

Baha M Sibai1, Dwight J Rouse.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27607853      PMCID： PMC5035205          DOI： 10.1097/AOG.0000000000001656

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN： 0029-7844            Impact factor:   7.661


× No keyword cloud information.
  10 in total

1.  VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Shannon M Bates; Ian A Greer; Saskia Middeldorp; David L Veenstra; Anne-Marie Prabulos; Per Olav Vandvik
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Maternal mortality in the United States: predictability and the impact of protocols on fatal postcesarean pulmonary embolism and hypertension-related intracranial hemorrhage.

Authors:  Steven L Clark; James T Christmas; Donna R Frye; Janet A Meyers; Jonathan B Perlin
Journal:  Am J Obstet Gynecol       Date:  2014-03-14       Impact factor: 8.661

Review 3.  Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery.

Authors:  R Collins; A Scrimgeour; S Yusuf; R Peto
Journal:  N Engl J Med       Date:  1988-05-05       Impact factor: 91.245

4.  A comparison of recommendations for pharmacologic thromboembolism prophylaxis after caesarean delivery from three major guidelines.

Authors:  K L Palmerola; M E D'Alton; C O Brock; A M Friedman
Journal:  BJOG       Date:  2015-10-05       Impact factor: 6.531

5.  Practice bulletin no. 123: thromboembolism in pregnancy.

Authors: 
Journal:  Obstet Gynecol       Date:  2011-09       Impact factor: 7.661

6.  The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus.

Authors:  Donna Dizon-Townson; Connie Miller; Baha Sibai; Catherine Y Spong; Elizabeth Thom; George Wendel; Katharine Wenstrom; Philip Samuels; Margaret A Cotroneo; Atef Moawad; Yoram Sorokin; Paul Meis; Menachem Miodovnik; Mary J O'Sullivan; Deborah Conway; Ronald J Wapner; Steven G Gabbe
Journal:  Obstet Gynecol       Date:  2005-09       Impact factor: 7.661

Review 7.  Pregnancy and venous thromboembolism: 'TIPPS' for risk stratification.

Authors:  Marc Rodger
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2014-11-18

Review 8.  Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period.

Authors:  Emily Bain; Agnes Wilson; Rebecca Tooher; Simon Gates; Lucy-Jane Davis; Philippa Middleton
Journal:  Cochrane Database Syst Rev       Date:  2014-02-11

Review 9.  Prevention of venous thromboembolism in general surgical patients. Results of meta-analysis.

Authors:  G P Clagett; J S Reisch
Journal:  Ann Surg       Date:  1988-08       Impact factor: 12.969

10.  Prothrombin gene G20210A mutation and obstetric complications.

Authors:  Robert M Silver; Yuan Zhao; Catherine Y Spong; Baha Sibai; George Wendel; Katharine Wenstrom; Philip Samuels; Steve N Caritis; Yoram Sorokin; Menachem Miodovnik; Mary J O'Sullivan; Deborah Conway; Ronald J Wapner
Journal:  Obstet Gynecol       Date:  2010-01       Impact factor: 7.623
  10 in total
  8 in total

1.  Implementation of a Risk-Based Heparin Protocol for Postpartum Venous Thromboembolism Prevention.

Authors:  Elizabeth Robison; Kent Heyborne; Amanda A Allshouse; Carolyn Valdez; Torri D Metz
Journal:  Obstet Gynecol       Date:  2017-08       Impact factor: 7.661

2.  Venous Thromboembolism Prophylaxis During Antepartum Admissions and Postpartum Readmissions.

Authors:  Anne H Mardy; Zainab Siddiq; Cande V Ananth; Jason D Wright; Mary E DʼAlton; Alexander M Friedman
Journal:  Obstet Gynecol       Date:  2017-08       Impact factor: 7.661

3.  Developing a model for predicting venous thromboembolism in obese pregnant women in a national study.

Authors:  Julia Ellis-Kahana; Andrew D Sparks; Alexis C Gimovsky; Andra H James; Homa K Ahmadzia
Journal:  Thromb Res       Date:  2020-04-23       Impact factor: 3.944

4.  Prevention and management of venous thromboembolism in pregnancy: cutting through the practice variation.

Authors:  Leslie Skeith
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

5.  Sequential compression device compliance in pregnant women requiring antepartum admission.

Authors:  Meinuo Chen; Kathryn A Sarnoski; Laura H Jacques; Timothy Klatt; Anna Palatnik
Journal:  J Matern Fetal Neonatal Med       Date:  2019-06-04

6.  Postpartum venous thromboembolism prophylaxis may cause more harm than benefit: a critical analysis of international guidelines through an evidence-based lens.

Authors:  A Kotaska
Journal:  BJOG       Date:  2018-03-07       Impact factor: 6.531

7.  Postpartum Heparin Thromboprophylaxis: More Harm Than Good.

Authors:  Andrew Kotaska
Journal:  Obstet Gynecol       Date:  2021-10-01       Impact factor: 7.661

Review 8.  Venous thromboembolism prophylaxis may cause more harm than benefit: an evidence-based analysis of Canadian and international guidelines.

Authors:  Andrew Kotaska
Journal:  Thromb J       Date:  2018-10-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.